Clorox Cleans Up in Q2, Expects Return to Growth

Clorox released better than expected fiscal second quarter financial results before the markets opened on Tuesday.

Published February 4, 2020, 10:00am ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A close-up, slightly angled shot of several Clorox bleach bottles lined up on a white retail shelf. The front bottle clearly shows the blue, red, and yellow diamond-shaped Clorox logo with 'CLOROX' in prominent white letters. The bottle also features text like 'Regular', '-Bleach', and 'CONCENTRATED' on a yellow band. Other identical bottles are blurred in the background, receding down the shelf. A red price tag is partially visible in the bottom right.
Rows of Clorox bleach bottles line a store shelf, symbolizing the enduring presence of consumer staples in both households and investment portfolios. The brand represents a long-term play in the market. © jeepersmedia / Flickr

Clorox Co. (NYSE: CLX) released its fiscal second-quarter financial results before the markets opened on Tuesday. The firm said that it had $1.46 in earnings per share (EPS) and $1.45 billion in revenue, which compared with consensus estimates of $1.31 in EPS and $1.43 billion in revenue. The same period of last year reportedly had $1.40 in EPS and $1.47 billion in revenue.

During the latest quarter, revenues declined by 2%, driven primarily by two points of unfavorable foreign currency exchange rates, but this was relatively flat on an organic basis.

In terms of its segments, Clorox reported:

  • Cleaning net revenues were relatively flat year over year at $501 million.
  • Household revenue decreased by 8% to $360 million.
  • Lifestyle revenue increased by 4% to $347 million.
  • International revenue decreased 2% to $241 million.

Looking ahead to the 2020 fiscal full year, the company expects to see EPS in the range of $6.10 to $6.25 and a low single-digit decrease to a 1% increase in sales (flat to 2% organic sales growth). Consensus estimates are calling for $6.14 in EPS and $6.18 billion in revenue for the full year.

[nativounit]

Benno Dorer, board chair and chief executive, commented:

I feel good about the progress we’re making, which is reflected in our second-quarter results, particularly the fifth consecutive quarter of gross margin expansion and sequential improvement in organic sales. We have confidence we’re taking the right steps as we expect to return to growth in the back half of the fiscal year behind strong investments in our robust innovation plans to support distribution. Importantly, we remain committed to strong execution behind our IGNITE strategy to deliver long-term shareholder value.

Shares of Clorox traded 4.5% higher early Tuesday, at $162.84 in a 52-week range of $144.12 to $166.90. The consensus price target is $147.00.
[recirclink id=643201]
[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

All articles →